Targeting EPHB2/ABL1 restores anti-tumor immunity in a preclinical model of ependymoma

被引：0
|
作者：
Ren, Jun
Amoozgar, Zohreh
Zhao, Yuhui
Lei, Pinji
Ho, William W.
Robergea, Sylvie
Huang, Peigen
Duda, Dan G.
Xu, Lei
Jain, Rakesh K.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2343
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2343
引用
收藏
页数：2
相关论文
共 50 条
  • [1] TARGETING EPHB2/ABL1 RESTORES ANTI-TUMOR IMMUNITY IN A PRECLINICAL MODEL OF EPENDYMOMA
    Ren, Jun
    Amoozgar, Zohreh
    Uccello, Taylor P.
    Zhao, Yuhui
    Lei, Pinji
    Ho, William W.
    Roberge, Sylvie
    Huang, Peigen
    Duda, Dan G.
    Xu, Lei
    Jain, Rakesh K.
    NEURO-ONCOLOGY, 2024, 26
  • [2] Targeting EPHB2/ABL1 restores anti-tumor immunity in a preclinical model of ependymoma
    Uccello, Taylor P.
    Ren, Jun
    Amoozgar, Zohreh
    Zhao, Yuhui
    Lei, Pin-Ji
    Ho, William W.
    Roberge, Sylvie
    Huang, Peigen
    Duda, Dan G.
    Xu, Lei
    Jain, Rakesh K.
    CANCER RESEARCH, 2024, 84 (05)
  • [3] Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymoma
    Ren, Jun
    Amoozgar, Zohreh
    Uccello, Taylor P.
    Lei, Pin - Ji
    Zhao, Yuhui
    Ho, William W.
    Huang, Peigen
    Kardian, Alisha
    Mack, Stephen C.
    Duda, Dan G.
    Xu, Lei
    Jain, Rakesh K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2025, 122 (04)
  • [4] Targeting tissue-resident macrophage progenitors restores anti-tumor immunity and suppresses tumor growth
    Chen, Hui
    Paradise, Marc
    Shepard, Ryan
    Wang, Guangfang
    Onaitis, Mark
    Varner, Judith
    CANCER RESEARCH, 2023, 83 (07)
  • [5] OMX IS A TUMOR MICROENVIRONMENT MODIFIER THAT RESTORES ANTI-TUMOR IMMUNITY AND IMPROVES ANTI-TUMOR EFFICACY BY REDUCING TUMOR HYPOXIA IN INTRACRANIAL GLIOBLASTOMA MOUSE MODEL
    Le Moan, Natacha
    Davis, Tina
    Leung, Philberta
    Ng, Sarah
    Winger, Jonathan
    Cary, Stephen
    Butowski, Nicholas
    Krtolica, Ana
    NEURO-ONCOLOGY, 2018, 20 : 259 - 259
  • [6] Targeting tissue-resident macrophage progenitors by anti-IL34 restores anti-tumor immunity and suppresses tumor growth
    Chen, Hui
    Zak, Jaroslav
    Paradise, Mark
    Wang, Guangfang
    Teijaro, John
    Onaitis, Mark
    Varner, Judith
    CANCER RESEARCH, 2024, 84 (06)
  • [7] Targeting Dectin-1 and or VISTA enhances anti-tumor immunity in melanoma but not colorectal cancer model
    Mashhouri, Siavash
    Rahmati, Amirhossein
    Azimi, Ako
    Fava, Roy A.
    Ismail, Ismail Hassan
    Walker, John
    Elahi, Shokrollah
    CELLULAR ONCOLOGY, 2024, 47 (05) : 1735 - 1756
  • [8] Targeting glycosylated PD-1 induces potent anti-tumor immunity
    Wang, Yuhan
    Sun, Linlin
    Yang, Riyao
    Liu, Jielin
    Qiu, Yufan
    Hsu, Jennifer L.
    Cha, Jong-ho
    Chan, Li-Chuan
    Hsu, Jung-Mao
    Lee, Heng-Huan
    Lai, Yun-Ju
    Khoo, Kay-Hooi
    Chung, Ezra M.
    Li, Chia-Wei
    Kim, Yong-Soo
    Park, Andrew H.
    Yang, Yi
    Yoo, Stephen S.
    Hung, Mien-Chie
    CANCER RESEARCH, 2020, 80 (16)
  • [9] Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model
    Veinalde, Ruta
    Pidelaserra-Marti, Gemma
    Moulin, Coline
    Tan, Chin Leng
    Schaefer, Theresa E.
    Kang, Na
    Ball, Claudia R.
    Leichsenring, Jonas
    Stenzinger, Albrecht
    Kaderali, Lars
    Jaeger, Dirk
    Ungerechts, Guy
    Engeland, Christine E.
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [10] Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer
    Zhang, Dongze
    Xie, Jinjing
    Sun, Fangxin
    Xu, Ruyan
    Liu, Wenjun
    Xu, Jia
    Huang, Xue
    Zhang, Guangbo
    CANCER LETTERS, 2024, 589
12345